181 related articles for article (PubMed ID: 15781229)
1. Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain.
Ni L; Zhu J; Zhang J; Yan M; Gao GF; Tien P
Biochem Biophys Res Commun; 2005 Apr; 330(1):39-45. PubMed ID: 15781229
[TBL] [Abstract][Full Text] [Related]
2. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
3. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
Yuan K; Yi L; Chen J; Qu X; Qing T; Rao X; Jiang P; Hu J; Xiong Z; Nie Y; Shi X; Wang W; Ling C; Yin X; Fan K; Lai L; Ding M; Deng H
Biochem Biophys Res Commun; 2004 Jul; 319(3):746-52. PubMed ID: 15184046
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.
Xu Y; Zhu J; Liu Y; Lou Z; Yuan F; Liu Y; Cole DK; Ni L; Su N; Qin L; Li X; Bai Z; Bell JI; Pang H; Tien P; Gao GF; Rao Z
Biochemistry; 2004 Nov; 43(44):14064-71. PubMed ID: 15518555
[TBL] [Abstract][Full Text] [Related]
6. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion.
Zhu J; Jiang X; Liu Y; Tien P; Gao GF
J Mol Biol; 2005 Dec; 354(3):601-13. PubMed ID: 16253271
[TBL] [Abstract][Full Text] [Related]
9. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
[TBL] [Abstract][Full Text] [Related]
10. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
Bosch BJ; van der Zee R; de Haan CA; Rottier PJ
J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899
[TBL] [Abstract][Full Text] [Related]
11. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
[TBL] [Abstract][Full Text] [Related]
12. Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins.
Polo-Megías D; Cano-Muñoz M; Berruezo AG; Laumond G; Moog C; Conejero-Lara F
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555153
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of human respiratory syncytial virus entry inhibitors.
Ni L; Zhao L; Qian Y; Zhu J; Jin Z; Chen YW; Tien P; Gao GF
Antivir Ther; 2005; 10(7):833-40. PubMed ID: 16312179
[TBL] [Abstract][Full Text] [Related]
14. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2.
Ling R; Dai Y; Huang B; Huang W; Yu J; Lu X; Jiang Y
Peptides; 2020 Aug; 130():170328. PubMed ID: 32380200
[TBL] [Abstract][Full Text] [Related]
15. Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
Liu IJ; Kao CL; Hsieh SC; Wey MT; Kan LS; Wang WK
Antiviral Res; 2009 Jan; 81(1):82-7. PubMed ID: 18983873
[TBL] [Abstract][Full Text] [Related]
16. An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry.
Lin X; Guo L; Lin S; Chen Z; Yang F; Yang J; Wang L; Wen A; Duan Y; Zhang X; Dai Y; Yin K; Yuan X; Yu C; He B; Cao Y; Dong H; Li J; Zhao Q; Lu G
Emerg Microbes Infect; 2022 Dec; 11(1):1920-1935. PubMed ID: 35757908
[TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
Yeung KS; Yamanaka GA; Meanwell NA
Med Res Rev; 2006 Jul; 26(4):414-33. PubMed ID: 16521129
[TBL] [Abstract][Full Text] [Related]
18. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism.
Guillén J; Pérez-Berná AJ; Moreno MR; Villalaín J
J Virol; 2005 Feb; 79(3):1743-52. PubMed ID: 15650199
[TBL] [Abstract][Full Text] [Related]
19. The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation.
Celigoy J; McReynolds S; Caffrey M
Biochem Biophys Res Commun; 2011 Sep; 412(3):483-6. PubMed ID: 21835164
[TBL] [Abstract][Full Text] [Related]
20. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing.
Elshabrawy HA; Coughlin MM; Baker SC; Prabhakar BS
PLoS One; 2012; 7(11):e50366. PubMed ID: 23185609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
